ReviewJournal of nuclear medicine : official publication, Society of Nuclear Medicine2017
Review in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.
- Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis.Annals of hematology · 2023Pooled it
- Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.The Cochrane database of systematic reviews · 2020Pooled it
- Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.The Cochrane database of systematic reviews · 2019Pooled it
- Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study.PloS one · 2019Trial
- Significant dose reduction employing dual-low-dose PET/CT in pediatric lymphoma: maintaining diagnostic, staging, and response-assessing efficacy.European radiology · 2026Article
- A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points.EJNMMI research · 2025Article
- PET/CT-Based prognostic model enhances early survival prediction in angioimmunoblastic t-cell lymphoma.Frontiers in immunology · 2025Article
- Metabolic tumor parameters complement clinicopathological factors in prognosticating advanced stage Hodgkin Lymphoma.Asia Oceania journal of nuclear medicine & biology · 2023Article
- The Prognostic Utility ofFrontiers in oncology · 2022Article
- Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at InterimJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021Article
- Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?Blood advances · 2021Article
- Assessment of cardiac tumors byJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Article
- The effect of hypothyroidism on referential background metabolic activity onQuantitative imaging in medicine and surgery · 2021Article
- Prognostic Value of Baseline Radiomic Features ofDiagnostics (Basel, Switzerland) · 2020Article
- Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R-CHOP.British journal of haematology · 2020Article
- Biomarker selection and imaging design in cancer: A link with biochemical pathways for imminent engineering.Heliyon · 2020Review
- Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.Pediatric radiology · 2019Review
- Article
- 18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.Medical science monitor : international medical journal of experimental and clinical research · 2019Article
- Metabolic tumor volume changes assessed by intervalOncology letters · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
PET/CT using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.